Biofilm-specific antibiotic resistance

Future Microbiology

Volumn 7, Issue 9, 2012, Pages 1061-1072

  Mah, Thien Fah ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

biofilm; biofilm specific antibiotic resistance mechanism; heterogeneity

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL INFECTION; BIOFILM; DRUG TRANSPORT; GENE EXPRESSION; GENE MUTATION; HUMAN; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; REVIEW;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PROTEINS; BIOFILMS; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS;

BACTERIA (MICROORGANISMS);

EID: 84866102281     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.12.76     Document Type: Review

References (108)

1. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Annu. Rev. Microbiol. 49, 711-745 (1995).
2. Stewart PS, Franklin MJ. Physiological heterogeneity in biofilms. Nat. Rev. Microbiol. 6(3), 199-210 (2008).
3. Sauer K, Camper AK. Characterization of phenotypic changes in Pseudomonas putida in response to surface-associated growth. J. Bacteriol. 183(22), 6579-6589 (2001).
4. Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J. Bacteriol. 184(4), 1140-1154 (2002).
5. Prigent-Combaret C, Vidal O, Dorel C, Lejune P. Abiotic surface sensing and biofilm-dependent regulation of gene expression in Eschericia coli. J. Bacteriol. 181(19), 5993-6002 (1999).
6. Waite RD, Paccanaro A, Papakonstantinopoulou A et al. Clustering of Pseudomonas aeruginosa transcriptomes from planktonic cultures, developing and mature biofilms reveals distinct expression profiles. BMC Genomics 7, 162-175 (2006).
7. Waite RD, Papakonstantinopoulou A, Littler E, Curtis MA. Transcriptome analysis of Pseudomonas aeruginosa growth: Comparison of gene expression in planktonic cultures and developing and mature biofilms. J. Bacteriol. 187, 6571-6576 (2005).
8. Hoyle BD, Costerton WJ. Bacterial resistance to antibiotics: The role of biofilms. Progr. Drug Res. 37, 91-105 (1991).
9. Hill D, Rose B, Pajkos A et al. Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. J. Clin. Microbiol. 43(10), 5085-5090 (2005).
10. Tabak M, Scher K, Hartog E et al. Effect of triclosan on Salmonella Typhimurium at different growth stages and in biofilms. FEMS Microbiol. Lett. 267, 200-206 (2006).
11. Teitzel GM, Parsek MR. Heavy metal resistance of biofilm and planktonic Pseudomonas aeruginosa. Appl. Environ. Microbiol. 69(4), 2313-2320 (2003).
12. Ceri H, Olsen ME, Stremick C, Read RR, Morck D, Buret A. The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J. Clin. Microbiol. 37(6), 1771-1776 (1999).
13. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 358(9276), 135-138 (2001).
14. Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9(1), 34-39 (2001).
15. O'Toole GA, Kaplan H, Kolter R. Biofilm formation as microbial development. Annu. Rev. Microbiol. 54, 49-79 (2000).
16. Alekshun MN, Levy SB. Molecular mechanisms of antibacterial multidrug resistance. Cell 128(6), 1037-1050 (2007).
17. Lewis K. Multidrug tolerance of biofilms and persister cells. Curr. Top. Microbiol. Immunol. 322, 107-131 (2008).
18. Parsek MR, Singh PK. Bacterial biofilms: An emerging link to disease pathogenesis. Ann. Rev. Microbiol. 57, 677-701 (2003).
19. Harmsen M, Yang L, Pamp SJ, Tolker- Nielsen T. An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal. FEMS Immunol. Med. Microbiol. 59(3), 253-268 (2010).
20. Bjarnsholt T, Jensen PO, Fiandaca MJ et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr. Pulmonol. 44(6), 547-558 (2009).
21. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407(6805), 762-764 (2000).
22. Wagner VE, Iglewski BH. P. aeruginosa biofilms in CF infection. Clin. Rev. Allergy Immunol. 35(3), 124-134 (2008).
23. Murray TS, Egan M, Kazmierczak BI. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients. Curr. Opin. Pediatr. 19, 83-88 (2007).
24. Sibley CD, Grinwis ME, Field TR et al. Culture enriched molecular profiling of the cystic fibrosis airway microbiome. PLoS One 6(7), e22702 (2011).
25. Sibley CD, Parkins MD, Rabin HR, Duan K, Norgaard JC, Surette MG. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc. Natl Acad. Sci. USA 105(39), 15070-15075 (2008).
26. Hadjifrangiskou M, Hultgren S. What does it take to stick around?: MOLECULAR insights into biofilm formation by uropathogenic Escherichia coli. Virulence 3, 3 (2012).
27. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301(5629), 105-107 (2003).
28. Anderson GG, Dodson KW, Hooton TM, Hultgren SJ. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis. Trends Microbiol. 12(9), 424-430 (2004).
29. Anderson GG, Martin SM, Hultgren SJ. Host subversion by formation of intracellular bacterial communities in the urinary tract. Microbes Infect. 6(12), 1094-1101 (2004).
30. Schilling JD, Lorenz RG, Hultgren SJ. Effect of trimethoprim- sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli. Infect. Immun. 70(12), 7042-7049 (2002).
31. Blango MG, Mulvey MA. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob. Agents Chemother. 54(5), 1855-1863 (2010).
32. Archer NK, Mazaitis MJ, Costerton JW, Leid JG, Powers ME, Shirtliff ME. Staphylococcus aureus biofilms: Properties, regulation, and roles in human disease. Virulence 2(5), 445-459 (2011).
33. Otto M: STAPHYLOCOCCUS epidermidis - the 'accidental' pathogen. Nat. Rev. Microbiol. 7(8), 555-567 (2009).
34. Kong KF, Vuong C, Otto M. Staphylococcus quorum sensing in biofilm formation and infection. Int. J. Med. Microbiol. 296(2-3), 133-139 (2006).
35. Yarwood JM, Bartels DJ, Volper EM, Greenberg EP. Quorum sensing in Staphylococcus aureus biofilms. J. Bacteriol. 186(6), 1838-1850 (2004).
36. Lequette Y, Greenberg EP. Timing and localization of rhamnolipid synthesis gene expression in Pseudomonas aeruginosa biofilms. J. Bacteriol. 187(1), 37-44 (2005).
37. Yang L, Barken KB, Skindersoe ME, Christensen AB, Givskov M, Tolker-Nielsen T. Effects of iron on DNA release and biofilm development by Pseudomonas aeruginosa. Microbiology 153(Pt 5), 1318-1328 (2007).
38. Webb JS, Thompson LS, James S et al. Cell death in Pseudomonas aeruginosa biofilm development. J. Bacteriol. 185(15), 4585-4592 (2003).
39. Yang L, Nilsson M, Gjermansen M, Givskov M, Tolker-Nielsen T. Pyoverdine and PQS mediated subpopulation interactions involved in Pseudomonas aeruginosa biofilm formation. Mol. Microbiol. 74(6), 1380-1392 (2009).
40. Lenz AP, Williamson KS, Pitts B, Stewart PS, Franklin MJ. Localized gene expression in Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol. 74(14), 4463-4471 (2008).
41. Williamson KS, Richards LA, Perez-Osorio AC et al. Heterogeneity in Pseudomonas aeruginosa biofilms includes expression of ribosome hibernation factors in the antibiotic tolerant subpopulation and hypoxia induced stress response in the metabolically active population. J. Bacteriol. 194(8), 2062-2073 (2012).
42. Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS. Extracellular DNA required for bacterial biofilm formation. Science 295(5559), 1487 (2002).
43. Mann EE, Wozniak DJ. Pseudomonas biofilm matrix composition and niche biology. FEMS Microbiol. Rev. 36(4), 893-916 (2011).
44. Walters MC 3rd, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob. Agents Chemother. 47(1), 317-323 (2003).
45. Suci PA, Mittelman MW, Yu FP, Geesey GG. Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms. Antimicrobial. Agents Chemother. 38(9), 2125-2133 (1994).
46. Ghafoor A, Hay ID, Rehm BH. Role of exopolysaccharides in Pseudomonas aeruginosa biofilm formation and architecture. Appl. Environ. Microbiol. 77(15), 5238-5246 (2011).
47. Khan W, Bernier SP, Kuchma SL, Hammond JH, Hasan F, O'Toole GA. Aminoglycoside resistance of Pseudomonas aeruginosa biofilms modulated by extracellular polysaccharide. Int. Microbiol. 13(4), 207-212 (2010).
48. Colvin KM, Gordon VD, Murakami K et al. The pel polysaccharide can serve a structural and protective role in the biofilm matrix of Pseudomonas aeruginosa. PLoS Pathog. 7(1), e1001264 (2011).
49. Wozniak DJ, Wyckoff TJ, Starkey M et al. Alginate is not a significant component of the extracellular polysaccharide matrix of PA14 and PAO1 Pseudomonas aeruginosa biofilms. Proc. Natl Acad. Sci. USA 100(13), 7907-7912. (2003).
50. Hentzer M, Teitzel GM, Balzer GJ et al. Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J. Bacteriol. 183(18), 5395-5401 (2001).
51. Leid JG, Willson CJ, Shirtliff ME, Hassett DJ, Parsek MR, Jeffers AK. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J. Immunol. 175(11), 7512-7518 (2005).
52. Otto M. Staphylococcal biofilms. Curr. Top. Microbiol. Immunol. 322, 207-228 (2008).
53. Sifri CD, Begun J, Ausubel FM. The worm has turned - microbial virulence modeled in Caenorhabditis elegans. Trends Microbiol. 13(3), 119-127 (2005).
54. Begun J, Gaiani JM, Rohde H et al. Staphylococcal biofilm exopolysaccharide protects against Caenorhabditis elegans immune defenses. PLoS Pathog. 3(4), e57 (2007).
55. Allesen-Holm M, Barken KB, Yang L et al. A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol. Microbiol. 59(4), 1114-1128 (2006).
56. Mulcahy H, Charron-Mazenod L, Lewenza S. Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog. 4(11), e1000213 (2008).
57. Wei Q, Tarighi S, Dotsch A et al. Phenotypic and genome-wide analysis of an antibiotic-resistant small colony variant (SCV) of Pseudomonas aeruginosa. PloS One 6(12), e29276 (2011).
58. Haussler S, Ziegler I, Lottel A et al. Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection. J. Med. Microbiol. 52(Pt 4), 295-301 (2003).
59. Drenkard E, Ausubel FM. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 416(6882), 740-743 (2002).
60. Starkey M, Hickman JH, Ma L et al. Pseudomonas aeruginosa rugose small-colony variants have adaptations that likely promote persistence in the cystic fibrosis lung. J. Bacteriol. 191(11), 3492-3503 (2009).
61. Lewis K. Persister cells. Ann. Rev. Microbiol. 64, 357-372 (2010).
62. Shah D, Zhang Z, Khodursky A, Kaldalu N, Kurg K, Lewis K. Persisters: A distinct physiological state of E. coli. BMC Microbiol. 6, 53 (2006).
63. Gerdes K, Christensen SK, Lobner-Olesen A. Prokaryotic toxin-antitoxin stress response loci. Nat. Rev. Microbiol. 3(5), 371-382 (2005).
64. Wang X, Wood TK. Toxin-antitoxin systems influence biofilm and persister cell formation and the general stress response. Appl. Environ. Microbiol. 77(16), 5577-5583 (2011).
65. Christensen SK, Gerdes K. RelE toxins from bacteria and archaea cleave mRNAs on translating ribosomes, which are rescued by tmRNA. Mol. Microbiol. 48(5), 1389-1400 (2003).
66. Harrison JJ, Wade WD, Akierman S et al. The chromosomal toxin gene yafQ is a determinant of multidrug tolerance for Escherichia coli growing in a biofilm. Antimicrob. Agents Chemother. 53(6), 2253-2258 (2009).
67. Kim JS, Heo P, Yang TJ et al. Bacterial persisters tolerate antibiotics by not producing hydroxyl radicals. Biochem. Biophys. Res. Comm. 413(1), 105-110 (2011).
68. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of cellular death induced by bacteriocidal antibiotics. Cell 130, 797-810 (2007).
69. Dwyer DJ, Kohanski MA, Collins JJ. Role of reactive oxygen species in antibiotic action and resistance. Curr. Opin. Microbiol. 12(5), 482-489 (2009).
70. Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS, O'Toole GA. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426(6964), 306-310 (2003).
71. Zhang L, Mah TF. The involvement of a novel efflux system in biofilm-specific resistance to antibiotics. J. Bacteriol. 190(13), 4447-4452 (2008).
72. Zhang L, Hinz AJ, Nadeau JP, Mah TF. Pseudomonas aeruginosa tssC1 links type VI secretion and biofilm-specific antibiotic resistance. J. Bacteriol. 193, 5510-5513 (2011).
73. Bhagwat AA, Gross KC, Tully RE, Keister DL. Beta-glucan synthesis in Bradyrhizobium japonicum: Characterization of a new locus (ndvC) influencing beta-(1->6) linkages. J. Bacteriol. 178(15), 4635-4642 (1996).
74. Bhagwat AA, Tully RE, Keister DL. Identification and cloning of a cyclic beta-(1->3), beta-(1->6)-d-glucan synthesis locus from Bradyrhizobium japonicum. FEMS Microbiol. Lett. 114(2), 139-144. (1993).
75. Sadovskaya I, Vinogradov E, Li J, Hachani A, Kowalska K, Filloux A. High-level antibiotic resistance in Pseudomonas aeruginosa biofilm: The ndvB gene is involved in the production of highly glycerol-phosphorylated B-(1-3)-glucans, which bind aminoglycosides. Glycobiology 20(7), 895-904 (2010).
76. Arellano-Reynoso B, Lapaque N, Salcedo S et al. Cyclic b-1, 2-glucan is a brucella virulence factor required for intracellular survival. Nat. Immunol. 6(6), 618-625 (2005).
77. Nett JE, Sanchez H, Cain MT, Andes DR. Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. J. Infect. Dis. 202(1), 171-175 (2010).
78. Vediyappan G, Rossignol T, d'Enfert C. Interaction of Candida albicans biofilms with antifungals: Transcriptional response and binding of antifungals to beta-glucans. Antimicrob. Agents Chemother. 54(5), 2096-2111 (2010).
79. Beaudoin T, Zhang L, Hinz AJ, Parr CJ, Mah TF. The Biofilm-specific antibiotic resistance gene, ndvB, is important for expression of ethanol oxidation genes in Pseudomonas aeruginosa biofilms. J. Bacteriol. 194(12), 3128-3136 (2012).
80. Winsor GL, Lam DK, Fleming L et al. Pseudomonas Genome Database: Improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res. 39(Database issue), D596-D600 (2011).
81. Balakrishnan L, Hughes C, Koronakis V. Substrate-triggered recruitment of the TolC channel-tunnel during type I export of hemolysin by Escherichia coli. J. Mol. Biol. 313(3), 501-510 (2001).
82. Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria: An update. Drugs 69(12), 1555-1623 (2009).
83. Pukatzki S, Ma AT, Sturtevant D et al. Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc. Natl Acad. Sci. USA 103(5), 1528-1533 (2006).
84. Pukatzki S, Mcauley SB, Miyata ST. The type VI secretion system: Translocation of effectors and effector-domains. Curr. Opin. Microbiol. 12, 11-17 (2009).
85. Bingle LEH, Bailey CM, Pallen MJ. Type VI secretion: A beginner's guide. Curr. Opin. Microbiol. 11, 3-8 (2008).
86. Filloux A, Hachani A, Bleves S. The bacterial type VI secretion machine: Yet another player for protein transport across membranes. Microbiology 154, 1570-1583 (2008).
87. Jani AJ, Cotter PA. Type VI secretion: Not just for pathogenesis anymore. Cell Host Microbe 8, 2-6 (2010).
88. Schwarz S, Hood RD, Mougous JD. What is type VI secretion doing in all those bugs? Trends Microbiol. 18(12), 531-537 (2010).
89. Schwarz S, West TE, Boyer F et al. Burkholderia type VI secretion systems have distinct roles in eukaryotic and bacterial cell interactions. PLoS Pathog. 6(8), e1001068 (2010).
90. Mougous JD, Cuff ME, Raunser S et al. A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus. Science 312, 1526-1530 (2006).
91. Bonemann G, Pietrosiuk A, Diemand HZ, Mogk A. Remodelling of VipA/VipB tubules by ClpV-mediated threading is crucial for type VI protein secretion. EMBO J. 28, 315-325 (2009).
92. Poole K. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56, 20-51 (2005).
93. Poole K. Stress responses as determinants of antimicrobial resistance in Gram-negative bacteria. Trends Microbiol. 20(5), 227-234 (2012).
94. Whiteley M, Bangera MG, Bumgarner RE et al. Gene expression in Pseudomonas aeruginosa biofilms. Nature 413(6858), 860-864 (2001).
95. Folsom JP, Richards L, Pitts B et al. Physiology of Pseudomonas aeruginosa in biofilms as revealed by transcriptome analysis. BMC Microbiol. 10, 294 (2010).
96. De Kievit TR, Parkins MD, Gillis RJ et al. Multidrug efflux pumps: Expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 45(6), 1761-1770 (2001).
97. Gillis RJ, White KG, Choi K-H, Wagner VE, Schweizer HP, Iglewski BH. Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 49(9), 3858-3867 (2005).
98. Lynch SV, Dixon L, Benoit MR et al. Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms. Antimicrob. Agents Chemother. 51, 3650-3658 (2007).
99. Klausen M, Aaes-Jorgensen A, Molin S, Tolker-Nielsen T. Involvement of bacterial migration in the development of complex multicellular structures in Pseudomonas aeruginosa biofilms. Mol. Microbiol. 50(1), 61-68 (2003).
100. Haagensen JA, Klausen M, Ernst RK et al. Differentiation and distribution of colistin-and sodium dodecyl sulfate-tolerant cells in Pseudomonas aeruginosa biofilms. J. Bacteriol. 189(1), 28-37 (2007).
101. Pamp SJ, Gjermansen M, Johansen HK, Tolker-Nielsen T. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol. Microbiol. 68(1), 223-240 (2008).
102. Macia MD, Perez JL, Molin S, Oliver A. Dynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/ pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment. Antimicrob. Agents Chemother. 55(11), 5230-5237 (2011).
103. Lai S, Tremblay J, Deziel E. Swarming motility: A multicellular behaviour conferring antimicrobial resistance. Environ. Microbiol. 11(1), 126-136 (2009).
104. Ryan RP, Fouhy Y, Garcia BF et al. Interspecies signalling via the Stenotrophomonas maltophilia diffusible signal factor influences biofilm formation and polymyxin tolerance in Pseudomonas aeruginosa. Mol. Microbiol. 68(1), 75-86 (2008).
105. Kaplan JB. Antibiotic-induced biofilm formation. Int. J. Artif. Organs 34(9), 737-751 (2011).
106. Hoffman LR, D'argenio DA, Maccoss MJ, Zhang Z, Jones RA, Miller SI. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436(7054), 1171-1175 (2005).
107. Nguyen D, Joshi-Datar A, Lepine F et al. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 334(6058), 982-986 (2011).
108. Yim G, Wang HH, Davies J. Antibiotics as signalling molecules. Philos. Trans. R. Soc. B Biol. Sci. 362(1483), 1195-1200 (2007).